3-nitro-2',5'-dimethylbiphenyl | 1426243-63-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-nitro-2',5'-dimethylbiphenyl
• 英文别名: 2,5-dimethyl-3'-nitro-1,1'-biphenyl；2',5'-dimethyl-3-nitrobiphenyl；1,4-dimethyl-2-(3-nitrophenyl)benzene
• CAS: 1426243-63-1
• 化学式: C₁₄H₁₃NO₂
• 分子量: 227.263
• InChiKey: CQYYQNXASWTLNQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.6
• 重原子数：
  17
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  45.8
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-nitro-2',5'-dimethylbiphenyl 在 palladium 10% on activated carbon 、 氢气 作用下， 以 甲醇 为溶剂， 20.0 ℃ 、303.99 kPa 条件下， 反应 8.0h， 以95%的产率得到2',5'-dimethylbiphenyl-3-amine
  参考文献：
  名称：

  Polynuclear Aromatic Amines as N-Nucleophiles in the ipso-Substitution of the Cyano Group in 1,2,4-Triazines

  摘要：

  The possibility of use of polynuclear aromatic amines as N-nucleophiles in the ipso-substitution of the 5-cyano group in 1,2,4-triazines has been studied. The influence of the structure of the aromatic amine on the result of the reaction has been demonstrated. With 3-aminobiphenyls the corresponding 5-amino-N-(biphenyl-3-yl)-1,2,4-triaizines have been obtained with yields of up to 88%.

  DOI：

  10.1134/s1070428020010268
• 作为产物：
  描述：

  3-硝基苯硼酸 在 trans-di(μ-acetato)bis[o-(di-o-tolylphosphino)benzyl]dipalladium(II) 、 三氟乙酸 作用下， 反应 48.0h， 生成 3-nitro-2',5'-dimethylbiphenyl
  参考文献：
  名称：

  Palladium-Catalyzed Arylation of Simple Arenes with Iodonium Salts

  摘要：

  The development of an arylation protocol for simple arenes with diaryliodonium salts using the Herrmann-Beller palladacycle catalyst is reported. The reaction takes simple aromatic feedstocks and creates valuable biaryls for use in all sectors of the chemical industry.

  DOI：

  10.1021/ol400412z

文献信息

• Azabicycloalkane compounds
  申请人：——

  公开号：US20040242622A1

  公开（公告）日：2004-12-02

  This invention provides compounds of formula I: 1 wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and R 7 are as defined in the specification, or a pharmaceutically acceptable salt or solvate or stereoisomer thereof. The compounds of this invention possess both &bgr; 2 adrenergic receptor agonist and muscarinic receptor antagonist activity. Such compounds are useful for treating pulmonary disorders, such as chronic obstructive pulmonary disease and asthma.

  这项发明提供了式I的化合物： 其中R1、R2、R3、R4、R5、R6和R7如规范中所定义，或其药用可接受盐、溶剂或立体异构体。本发明的化合物具有β2肾上腺素受体激动剂和肌碱受体拮抗剂活性。这些化合物对治疗肺部疾病，如慢性阻塞性肺病和哮喘，是有用的。
• Perylenequinonoid-catalyzed photoredox activation for the direct arylation of (het)arenes with sunlight
  作者：Shiwei Zhang、Zhaocheng Tang、Wenhao Bao、Jia Li、Baodang Guo、Shuping Huang、Yan Zhang、Yijian Rao

  DOI：10.1039/c9ob00659a

  日期：——

  and photobiology. However, their applications in photocatalysis are yet to be explored. We report here that sunlight along with 1 mol% cercosporin, which is one of the perylenequinonoid pigments, catalyzes the direct C–H bond arylation of (het)arenes by a photoredox process with good regioselectivity and broad functional group compatibility. Furthermore, a gram-scale reaction with great conversions

  天然存在的per醌类颜料（PQP）由于其出色的光敏性能而备受关注。作为光物理和光生物学的一个方面，它们已被广泛研究。然而，它们在光催化中的应用尚待探索。我们在这里报告说，阳光与1 mol％的头孢菌素（一种ylene醌类颜料之一）通过光氧化还原过程以良好的区域选择性和广泛的官能团相容性催化（杂）芳烃的直接C–H键芳基化。此外，即使通过含头孢菌素的上清液在液体发酵后不进行有机溶剂萃取和纯化的情况下，也实现了具有很大底物转化率的克级反应。
• Compounds having beta adrenergic receptor agonist and muscarinic receptor antagonist activity
  申请人：Mammen Mathai

  公开号：US20060035933A1

  公开（公告）日：2006-02-16

  This invention provides compounds of formula I: wherein R 1 , R 2 , R 4 , R 5 , R 6 , R 7 , R 8a , R 8b , W, a, b, c and m are as defined in the specification, or a pharmaceutically acceptable salt or solvate or stereoisomer thereof. The compounds of this invention possess both β 2 adrenergic receptor agonist and muscarinic receptor antagonist activity. Accordingly, such compounds are expected to be useful as therapeutic agents for treating pulmonary disorders, such as chronic obstructive pulmonary disease and asthma.

  这项发明提供了式I的化合物：其中R1、R2、R4、R5、R6、R7、R8a、R8b、W、a、b、c和m如规范中所定义，或其药学上可接受的盐、溶剂或立体异构体。本发明的化合物具有β2肾上腺素受体激动剂和肌碱受体拮抗剂活性。因此，这些化合物预计可用作治疗肺部疾病，如慢性阻塞性肺病和哮喘的治疗剂。
• Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
  申请人：Mammen Mathai

  公开号：US20050113417A1

  公开（公告）日：2005-05-26

  The invention is directed to compounds of formula I: wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7a , R 7b , W, G 1 , G 2 , a, b, c, d and m are as defined in the specification, or a pharmaceutically acceptable salt or solvate or stereoisomer thereof. The invention is also directed to pharmaceutical compositions comprising such compounds; methods of using such compounds; and process and intermediates for preparing such compounds.

  这项发明涉及到以下式I的化合物：其中R1、R2、R3、R4、R5、R6、R7a、R7b、W、G1、G2、a、b、c、d和m如规范中所定义，或其药学上可接受的盐、溶剂或立体异构体。该发明还涉及包含这些化合物的药物组合物；使用这些化合物的方法；以及制备这些化合物的过程和中间体。
• Biphenyl derivatives
  申请人：——

  公开号：US20040167167A1

  公开（公告）日：2004-08-26

  This invention provides biphenyl derivatives of formula I: 1 wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , W, a, b and c are as defined in the specification, or a pharmaceutically acceptable salt or solvate or stereoisomer thereof. The biphenyl derivatives of this invention possess both &bgr; 2 adrenergic receptor agonist and muscarinic receptor antagonist activity and therefore, such biphenyl derivatives are useful for treating pulmonary disorders, such as chronic obstructive pulmonary disease and asthma.

  这项发明提供了式I中的联苯衍生物：其中R1、R2、R3、R4、R5、R6、R7、W、a、b和c如规范中定义，或其药学上可接受的盐、溶剂或立体异构体。本发明的联苯衍生物具有β2肾上腺素受体激动剂和肌力抑制剂活性，因此，这种联苯衍生物可用于治疗肺部疾病，如慢性阻塞性肺疾病和哮喘。